At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 34 enrolled
Drug / intervention
DBI-002 probiotic gel +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults With Tinea Versicolor
In Brief
A Phase 2 clinical trial evaluating DBI-002 probiotic gel and Aqueous gel for Tinea Versicolor. Completed, enrolled 34 participants across 1 site.
Detailed Summary
A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults with Tinea Versicolor (DBI-202).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinea Versicolor
CountriesEl Salvador
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedJun 2021
Primary CompletionSep 2021
Study CompletionNov 2021
TodayJul 2026
First PostedJun 24, 2021
Enrollment StartMar 16, 2021
Primary CompletionSep 20, 2021
Study CompletionNov 4, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.0 years ago
Interventions
DBI-002 probiotic gelbiological
Topical application on skin affected with tinea versicolor
Aqueous gelbiological
Topical application on skin affected with tinea versicolor